Top Ten most popular articles on Pharmafile.com this week

pharmafile | June 21, 2019 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten 

It’s Friday, and time for another run-down of the week’s most popular articles. The FDA has asked US firm MSD to join its shared permission blockchain network in order to more effectively track and trace its products in the US; don’t miss our full-length feature on how blockchain is helping elsewhere in tackling some of the industry’s greatest challenges.

In other news, warnings have been issued yet again of the damage a no-deal Brexit scenario would cause to drug access and pricing in the UK, while scientists at King’s College London say they have identified the earliest signs of Parkinson’s disease in the brain.

Check out the top ten most popular stories on Pharmafile.com this week!

10. The missing link: Blockchain in clinical data management

Louis Goss explores the potential uses for the much-hyped technology blockchain as a tool to tackle the data management challenges faced by the pharmaceutical and life sciences industries

9. No-deal Brexit could cause shortages and higher prices, healthcare distributors warn

The Healthcare Distribution Association (HDA) has warned MPs that Britain could face shortages of medicines if it were to leave the European Union (EU) without a deal on 31 October.

8. FDA asks MSD to join blockchain supply chain network

The FDA has asked MSD to join a shared permission blockchain network to help track and trace prescription medicines and vaccines distribution in the United States.

7. EU pharmaceutical industry lost €16.5 billion in sales as staff shift to patent infringing firms

A report from the European Union Intellectual Property Office (EUIPO) has said ‘counterfeit’ drugs cost the EU pharmaceutical industry €16.5 billion.

6. Teva recalls heart drug after carcinogen found in API

Teva Pharmaceuticals has expanded its recall of losartan potassium tablets after detecting a possible carcinogen in an active pharmaceutical ingredient (API).

5. Drugmakers sue Trump over prices in TV ads

Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to include prices in TV ads.

4. Boehringer Ingelheim opens new plant in Catalonia

Boehringer Ingelheim has opened a new manufacturing facility in the town of Sant Cugat del Vallès near Barcelona.

3. GSK launches sale of consumer healthcare brands

The sale comes as GSK seeks to raise £1 billion before it folds its consumer healthcare business into a joint venture with American drugmaker Pfizer.

2. Patient dies after receiving faecal transplant

The FDA has warned that two immunocompromised patients developed invasive infections caused by multi drug resistant bacteria, after receiving a faecal transplant.

1. Scientists at King’s College London identify early signs of Parkinson’s disease

Scientists at King’s College London say they have identified the earliest signs of Parkinson’s disease in the brain – 15 to 20 years before symptoms appear.

Related Content

FDA approves first oral antiviral to treat adult patients with COVID-19

The US Food and Drug Administration (FDA) has announced that it has approved the oral …

ZOLL remedē System receives FDA approval for sleep apnoea treatment

ZOLL Medical Corporation has announced that it has received approval from the US Food and …

Artivion receives FDA PMA approval of PerClot; transfers designation to Baxter

US cardiac and vascular surgery company Artivion has announced that the US Food and Drug …

Latest content